Cargando...
Triple-negative breast cancer and the potential for targeted therapy
Breast cancer is composed of several well-recognized subtypes including estrogen receptor, progesterone receptor and HER2 triple-negative breast cancer (TNBC). Without available targeted therapy options, standard of care for TNBC remains chemotherapy. It is of interest to note that TNBC tumors gener...
Gardado en:
| Publicado en: | Pharmacogenomics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694022/ https://ncbi.nlm.nih.gov/pubmed/29095114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2017-0117 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|